Low-dose aspirin for primary prevention of cardiovascular events in patients with diabetes: Benefit or risk?
Leggio, M., Bendini, M.G., Caldarone, E., Lombardi, M., Severi, P., D’Emidio, S., Stavri, D.C., Armeni, M., Bravi, V., Mazza, A.Language:
english
Journal:
Diabetes & Metabolism
DOI:
10.1016/j.diabet.2017.11.002
Date:
November, 2017
File:
PDF, 459 KB
english, 2017